Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects

American Heart Journal

Volumn 131, Issue 2, 1996, Pages 313-319

  Himeno, Etsuro ^a   Nishino, Kenji ^b   Nakashima, Yoshiyuki ^c   Kuroiwa, Akio ^a   Ikeda, Masaharu ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Nishino Hospital   (Japan)

^c FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE; HEART WEIGHT; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0030022583     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90360-9     Document Type: Article

References (35)

1. Tobian L. Hypertension and obesity. N Engl J Med 1978;298:46-8.
2. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension: the Framingham Study. Ann Intern Med 1967;67:48-59.
3. Kannel WB, Gordon T, Castelli WP. Obesity, lipids, and glucose intolerance: the Framingham Study. Am J Clin Nutr 1979;32:1238-45.
4. Wilson PW, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am J Epidemiol 1981;114:697-704.
5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
6. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Study. JAMA 1991;266:231-6.
7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med 1990;322:1561-6.
8. Gillum RF, Prineas RJ, Jeffery RW, Jacobs DR, Elmer PJ, Gomez O, Blackburn H. Nonpharmaeologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in over-weight borderline hypertensive patients. AM HEART J 1983;105:128-33.
9. Fagerberg B, Andersson O, Isaksson B, Bjørntorp P. Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction. Br Med J 1984;288:11-14.
10. Dahl LK. Salt and hypertension. Am J Clin Nutr 1972;25:231-44.
11. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978; 298:1-6.
12. Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM Jr. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983;98:315-19.
13. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese subjects. N Engl J Med 1981;304:930-3.
14. Tuck ML, Sowers JR, Dornfeld L, Whitfield L, Maxwell M. Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol 1983;102:252-7.
15. MacMahon SW, Wilcken DEL, Macdonald GJ. The effect of weight reduction on left ventricular mass; a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986;314:334-9.
16. Ferrara LA, Simone G, Pasanisi F, Mancini M, Mancini M. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension 1984;6:755-9.
17. Matsusaki M, Ikeda M, Tashiro E, Koga M, Miura S, Ideishi M, Tanaka H, Shindo M, Arakawa K. Influence of workload on the antihypertensive effect of exercise. Clin Exp Pharmacol Physiol 1992;19:471-9.
18. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989; 79:324-9.
19. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988;78:506-15.
20. Taniguchi K, Itoh H, Yajima T, Doi M, Niwa A, Marumo F. Predischarge exercise therapy in patients with acute myocardial infarction on the basis of anaerobic threshold (AT). Jpn Circ J 1990;54:1419-25.
21. Wasserman K. The anaerobic threshold: definition, physiological significance and identification. Adv Cardiol 1986;35:1-23.
22. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-18.
23. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC. Echocardiographically detected left ventricular hypertrophy; prevalence and risk factors, the Framingham Heart Study. Ann Intern Med 1988;108:7-13.
24. Beaver. WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7.
25. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88:1431-6.
26. Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992;69:440-4.
27. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967;46:1756-67
28. Olefsky J, Reaven GM, Farquhar JW. Effects of weight reduction on obesity: studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 1974;53:64-76.
29. Sims EAH, Berchtold P. Obesity and hypertension: mechanisms and implications for management. JAMA 1982;247:49-52.
30. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-25.
31. Bjørntorp P, Jounge K, Sjøstrøm L, Sullivan L. The effect of physical training on insulin production in obesity. Metabolism 1970;19:631-7.
32. Arakawa K. Antihypertensive mechanism of exercise. J Hypertens 1993;11:223-9.
33. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation 1988;78:951-6.
34. Weber KT, Janicki JS. Angiotensin and the remodelling of the myocardium. Br J Clin Pharmacol 1989;28:141S-50S.
35. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984;53:1044-9.